A 21–35 kDa Mixed Protein Component from Helicobacter pylori Activates Mast Cells Effectively in Chronic Spontaneous Urticaria

Helicobacter

Volumn 21, Issue 6, 2016, Pages 565-574

  Tan, Ran Jing ^a,b   Sun, He Qiang ^b   Zhang, Wei ^a   Yuan, Han Mei ^b   Li, Bin ^b   Yan, Hong Tao ^a   Lan, Chun Hui ^a   Yang, Jun ^a   Zhao, Zhuo ^b   Wu, Jin Jin ^a   Wu, Chao ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

activation effect; Chronic spontaneous urticaria; Helicobacter pylori; mast cells; mixed protein component

Indexed keywords

GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 3; LEUKOTRIENE B4; TUMOR NECROSIS FACTOR; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CHRONIC SPONTANEOUS URTICARIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MAST CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; URTICARIA; BLOOD; CELL LINE; CHEMISTRY; DNA SEQUENCE; IMMUNOLOGY; MIDDLE AGED; MOLECULAR WEIGHT; PATHOLOGY; SERUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELL LINE; CHROMATOGRAPHY, LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MALE; MASS SPECTROMETRY; MAST CELLS; MIDDLE AGED; MOLECULAR WEIGHT; SEQUENCE ANALYSIS, DNA; SERUM; URTICARIA; YOUNG ADULT;

EID: 84963741516     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/hel.12312     Document Type: Article

References (41)

1. 2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014;69:868–87.
2. Shimoyama T, Umegaki N, Mikami T, Nakano H, Munakata A. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004;39:827–30.
3. Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007;12:567–71.
4. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009;5:10.
5. Cascio A, Barberi G, Gangemi S. Urticaria and bacterial infections. Allergy Asthma Proc 2014;35:295–302.
6. Gu H, Li L, Gu M, Zhang G. Association between Helicobacter pylori Infection and Chronic Urticaria: a Meta-Analysis. Gastroenterol Res Pract 2015;2015:486974.
7. Ott VL, Cambier JC. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;106:429–40.
8. Shiotani A, Okada K, Yanaoka K, et al. Beneficial effect of Helicobacter pylori eradication in dermatologic diseases. Helicobacter 2001;6:60–5.
9. Mini R, Figura N, D'Ambrosio C, et al. Helicobacter pylori immuneproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005;5:777–87.
10. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449–90.
11. Liutu M, Kalimo K, Uksila J, Savolainen J. Extraction of IgE-binding components of Helicobacter pylori by immunoblotting analysis in chronic urticaria patients. Int Arch Allergy Immunol 2001;126:213–7.
12. Bechi P, Dei R, Di Bello MG, Masini E. Helicobacter pylori Potentiates Histamine Release from Serosal Rat Mast Cells in Vitro. Dig Dis Sci 1993;38:944–9.
13. Masini E, Bechi P, Dei R, Di Bello MG, Sacchi TB. Helicobacter pylori Potentiates Histamine Release from Rat Serosal Mast Cells Induced by Bile Acids. Dig Dis Sci 1994;39:1493–500.
14. Supajatura V, Ushio H, Wada A, et al. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002;168:2603–7.
15. de Bernard M, Cappon A, Pancotto L, et al. The Helicobacter pylori VacA cytotoxin activates RBL-2H3 cells by inducing cytosolic calcium oscillations. Cell Microbiol 2005;7:191–8.
16. Velin D, Bachmann D, Bouzourene H, Michetti P. Mast Cells Are Critical Mediators of Vaccine-Induced Helicobacter Clearance in the Mouse Model. Gastroenterology 2005;129:142–55.
17. Tsai CC, Kuo TY, Hong ZW, et al. Helicobacter pylori neutrophil-activating protein induces release of histamine and interleukin-6 through G protein-mediated MAPKs and PI3K/Akt pathways in HMC-1 cells. Virulence 2015;6:755–65.
18. Wu C, Shi Y, Guo H, et al. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine. Helicobacter 2008;13:191–9.
19. Harsha HC, Molina H, Pandey A. Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat Protoc 2008;3:505–516.
20. Moreira A, Rodrigues J, Delgado L, Fonseca J, Vaz M. Is Helicobacter pylori infection associated with chronic idiopathic urticarial. Allergol Immunopathol 2003;31:209–14.
21. Shakouri A, Compalati E, Lang DM, Khan DA. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol 2010;10:362–9.
22. Curth HM, Dinter J, Nigemeier K, Kütting F, Hunzelmann N, Steffen HM. Effects of Helicobacter pylori Eradication in Chronic Spontaneous Urticaria: results from a Retrospective Cohort Study. Am J Clin Dermatol 2015;16:553–8.
23. Velin D, Michetti P. Immunology of Helicobacter pylori infection. Digestion 2006;73:116–23.
24. Wessler S, Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol 2008;16:397–405.
25. Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 2010;10:440–52.
26. Hofman V, Lassalle S, Selva E, et al. Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis. J Clin Pathol 2007;60:600–7.
27. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007;7:93–104.
28. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008;454:445–54.
29. Vonakis BM, Saini SS. New concepts in chronic urticaria. Curr Opin Immunol 2008;20:709–16.
30. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007;217:304–28.
31. Munitz A, Bachelet I, Eliashar R, et al. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol 2006;177:77–83.
32. Weller CL, Collington SJ, Brown JK, et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 2005;201:1961–71.
33. Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SG, Emergency Department Anaphylaxis Investigators. Elevated serum cytokines during human anaphylaxis: identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol 2009;124:786–92.e4.
34. Ying S, Kikuchi Y, Meng Q, Kay AB, Kaplan AP. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002;109:694–700.
35. Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol 2014;28:469–74.
36. Galli S, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135–42.
37. Chan CY, St John AL, Abraham SN. Plasticity in mast cell responses during bacterial infections. Curr Opin Microbiol 2012;15:78–84.
38. Marshall JS. Mast-cell responses to pathogens. Nat Rev Immunol 2004;4:787–99.
39. Talreja J, Kabir MH, B Filla M, Stechschulte DJ, Dileepan KN. Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Grampositive and Gram-negative bacterial cell wall components. Immunology 2004;113:224–33.
40. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008;76:4489–97.
41. Olivera-Severo D, Wassermann GE, Carlini CR. Ureases display biological effects independent of enzymatic activity: is there a connection to diseases caused by urease-producing bacteria. Braz J Med Biol Res 2006;39:851–61.